Product Comparison


 

No Image

Merck 00006412102 Grifols Therapeutics Inc (TDVAX) 13533013101 Merck 00006483703 Merck 00006404741
McKesson # 1198028 952614 981867 911398 544446
Description Humiraᆴ Adalimumab 40 mg / 0.8 mL Injection Prefilled Auto-Injector 6 Doses Gardasil® 9 Human Papillomavirus Vaccine (HPV) Indicated for People 9 to 45 Years of Age 20 mcg - 60 mcg / 0.5 mL Injection Prefilled Syringe Intramuscular TDVAX™ Td Vaccine Indicated for People 7 Years of Age and Older Tetanus and Diphtheria Toxoids Adsorbed Injection Single-Dose Vial 0.5 mL Pneumovax® 23 Pneumonia Vaccine Indicated for People 50 Years of Age and Older Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL RotaTeq® Rotavirus Vaccine Indicated for People 6 to 32 Weeks of Age Solution Single-Dose Tube 2 mL
Manufacturer # 0007443390600006412102135330131010000648370300006404741
Brand  Gardasil® 9TDVAX™Pneumovax® 23RotaTeq®
Manufacturer AbbVie IncMerckGrifols Therapeutics Inc (TDVAX)MerckMerck
Invoice  GARDASIL 9 HPV VACC, SYR 0.5ML(10/BX) MRKVACTDVAX, SDV 0.5ML (10/PK)PNEUMOVAX, SYR 0.5ML (10/CT)ROTATEQ VAC, SUSP 2ML LIVE PENTAV (10/PK)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Application Human Papillomavirus Vaccine (HPV)Td VaccinePneumonia VaccineRotavirus Vaccine
Container Type Prefilled SyringeSingle-Dose VialPrefilled SyringeSingle-Dose Tube
Country of Origin UnknownUnited StatesUnknownUnited StatesUnited States
Dosage Form InjectionInjectionInjectionSolution
Generic Drug Code 37568208354385926500
Generic Drug Name Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative FreeTetanus and Diphtheria Toxoids AdsorbedPneumococcal 23 Vaccine PolyvalentRotavirus Vaccine, Live, Oral Pentavalent
NDC Number 00006412102135330131010000648370300006404741
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Strength 20 mcg - 60 mcg / 0.5 mL2 Lf - 2 Lf / 0.5 mL25 mcg / 0.5 mL
Type IntramuscularIntramuscularIntramuscular or SubcutaneousOral
UNSPSC Code 51201649512016295120161551201618
User Indicated for People 9 to 45 Years of AgeIndicated for People 7 Years of Age and OlderIndicated for People 50 Years of Age and OlderIndicated for People 6 to 32 Weeks of Age
Volume 0.5 mL0.5 mL0.5 mL2 mL
Features and Benefits
  • GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58
  • Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein
  • Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months
  • Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58
  • PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
  • PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
  • Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
  • Store unopened and opened vials at 2° - 8°C (36° - 46°F)
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • 10 individually pouched single dose tubes
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration